TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Chiron Pharmasynth AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
15,551
|
9,553
|
8,890 |
Financial expenses |
131
|
137
|
124 |
Earnings before taxes |
2,001
|
3,943
|
4,721 |
Total assets |
30,085
|
26,190
|
20,677 |
Current assets |
30,085
|
26,190
|
20,663 |
Current liabilities |
11,502
|
10,017
|
6,894 |
Equity capital |
18,583
|
16,173
|
13,783 |
- share capital |
1,876
|
1,820
|
1,694 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
61.8%
![]() |
61.8%
|
66.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
12.9%
|
41.3%
|
53.1% |
Return on assets (ROA) |
7.1%
|
15.6%
|
23.4% |
Current ratio |
261.6%
|
261.5%
|
299.7% |
Return on equity (ROE) |
10.8%
|
24.4%
|
34.3% |
Change turnover |
5,702
|
3
|
-1,589 |
Change turnover % |
58%
|
0%
|
-15% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.